Relationship and significance between anti-β2-glycoproteinI antibodies and platelet activation state in patients with ulcerative colitis

Table 2 Positive expression rate for platelet activation marker in different groups of patients (%, mean ± SD)

Group	n	PAC-I	CD62P
Active UC group	36	30.6 ± 7.6bd	45.0 ± 8.8bd
Remittent UC group	20	19.6 ± 7.8b	31.9 ± 7.8b
Control group	25	6.3 ± 1.7	9.2 ± 2.7

^bP < 0.01 vs control group;

^dP < 0.01 vs remittent UC group.